• Home
  • Contact
  •  NL 
  • Login medewerkers
  • mijnUMCG

Publicaties 2013

Print 

Adelmeijer J, Porte RJ, Lisman T.
In vitro effects of proteases in human pancreatic juice on stability of liquid and carrier-bound fibrin sealants.
Br J Surg. 2013 Oct;100(11):1498-504.

Arshad F, Lisman T, Porte RJ.
Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient.
Liver Int. 2013 Jul;33(6):820-7.

Arshad F, Ickx B, van Beem RT, Polak W, Grüne F, Nevens F, Ilmakunnas M, Koivusalo AM, Isoniemi H, Strengers PF, Groen H, Hendriks HG, Lisman T, Pirenne J, Porte RJ.
Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial.
BMC Surg. 2013 Jul 1;13:22.

de Boer MT, Porte RJ.
Reply to Letter: "Fibrin Sealants Do Not Prevent Resection Surface-Related Complications After Liver Resection"
Ann Surg. 2013 Oct 3.

Braat AE, Blok JJ, Rahmel AO, Adam R, Burroughs AK, Putter H, Porte RJ, Rogiers X, Ringers J Incorporation of donor risk into liver allocation algorithms.  
Am J Transplant. 2013 Feb;13(2):524-5.

op den Dries S, Karimian N, Sutton ME, Westerkamp AC, Nijsten MW, Gouw AS, Wiersema-Buist J, Lisman T, Leuvenink HG, Porte RJ.
Ex vivo Normothermic Machine Perfusion and Viability Testing of Discarded Human Donor Livers.
Am J Transplant. 2013 May;13(5):1327-35.

op den Dries S, Karimian N, Weeder PD, Porte RJ.
Normothermic acellular machine perfusion and bile duct injury in pig livers retrieved after cardiac death.
Am J Transplant. 2013 Dec;13(12):3289.

op den Dries S, Karimian N, Porte RJ.
Normothermic machine perfusion of discarded liver grafts.
Am J Transplant. 2013 Sep;13(9):2504.

van der Hilst CS, Ijtsma AJ, Bottema JT, van Hoek B, Dubbeld J, Metselaar HJ, Kazemier G, van den Berg AP, Porte RJ, Slooff MJ.
The price of donation after cardiac death in liver transplantation: a prospective cost-effectiveness study.
Transpl Int. 2013 Apr;26(4):411-8.

Hugenholtz GC, Adelmeijer J, Meijers JC, Porte RJ, Stravitz RT, Lisman T.
An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: Implications for hemostasis and clinical outcome.
Hepatology. 2013 Aug;58(2):752-61.

Hugenholtz GC, Meijers JC, Adelmeijer J, Porte RJ, Lisman T.
TAFI deficiency promotes liver damage in murine models of liver failure through defective down-regulation of hepatic inflammation.
Thromb Haemost. 2013 May 2;109(5):948-55.

Janse M, de Rooij BJ, van Hoek B, van den Berg AP, Porte RJ, Blokzijl H, Coenraad MJ, Hepkema BG, Schaapherder AF, Ringers J, Weersma RK, Verspaget HW.
Recipient's genetic R702W NOD2 variant is associated with an increased risk of bacterial infections after orthotopic liver transplantation.
PLoS One. 2013 Aug 19;8(8):e72617.

Karimian N, Op den Dries S, Porte RJ.
The origin of biliary strictures after liver transplantation: is it the amount of epithelial injury or insufficient regeneration that counts?
J Hepatol. 2013 Jun;58(6):1065-7.

Kele PG, van der Jagt EJ, Gouw AS, Lisman T, Porte RJ, de Boer MT.
The impact of hepatic steatosis on liver regeneration after partial hepatectomy.
Liver Int. 2013 Mar;33(3):469-75.

Lisman T, Kamphuisen PW, Northup PG, Porte RJ.
Established and new-generation antithrombotic drugs in patients with cirrhosis - Possibilities and caveats.
J Hepatol. 2013 Aug;59(2):358-66.

Orlando G, Adam R, Mirza D, Soderdahl G, Porte RJ, Paul A, Burroughs AK, Seiler CA, Colledan M, Graziadei I, Garcia Valdecasas JC, Pruvot FR, Karam V, Lerut J.
Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation--the European Liver Transplant Registry experience.
Transplantation. 2013 Mar 27;95(6):872-7.

Potze W, Arshad F, Adelmeijer J, Blokzijl H, van den Berg AP, Meijers JC, Porte RJ, Lisman T.
Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels.
Br J Haematol. 2013 Sep;162(6):819-26.

Potze W, Arshad F, Adelmeijer J, Blokzijl H, van den Berg AP, Meijers JC, Porte RJ, Lisman T.
Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis.
Br J Haematol. 2013 Dec;163(5):666-73.

de Ridder J, van Walsum M, Verhoef C, Nagtegaal I, de Wilt J; Dutch Liver Working Group.
Hepatic resection for metastatic melanoma in The Netherlands: survival and prognostic factors.
Melanoma Res. 2013 Feb;23(1):27-32.